endometrial cancer - (neo)adjuvant (NA) | |
endometrial cancer - (neo)adjuvant (NA) | |
pembrolizumab plus SoC | KEYNOTE-B21 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -